Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04111536 Completed - Clinical trials for Heart Failure With Preserved Ejection Fraction

Developing Oral LT3 Therapy for Heart Failure - HFpEF

DOT3HF-HFpEF
Start date: March 8, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Investigation of the safety, feasibility, and preliminary efficacy of thyroid hormone therapy with Liothyronine (LT3) in individuals with heart failure with preserved ejection fraction (HFpEF) and low triiodothyronine (T3) syndrome by conducting a randomized, double-blind, placebo-controlled cross-over study with a two-week washout period between treatments.

NCT ID: NCT04111510 Completed - Clinical trials for Metastatic Triple Negative Breast Cancer

Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer

Start date: December 23, 2019
Phase: Phase 2
Study type: Interventional

This study will investigate the safety and efficacy of TIL therapy in patients with metastatic TNBC who have progressed on at least one and no more than three prior systemic anticancer therapies.

NCT ID: NCT04110899 Completed - Clinical trials for Anesthesia Intubation Complication

Paratracheal Force Required for Occluding the Upper Esophagus

Start date: March 3, 2020
Phase: N/A
Study type: Interventional

In this study, the median paratracheal force for occluding the upper esophagus are evaluated in anesthetized and paralyzed patients using the up-and-down technique.

NCT ID: NCT04110600 Completed - Clinical trials for Gastrointestinal Motility and Defecation Conditions

Efficacy of Coffee Versus Peppermint Oil Intake in Promoting GIT Motility After Cesarean Section

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

It is a comparison between coffee effect versus peppermint oil in promoting GIT motility after cesarean section

NCT ID: NCT04110587 Completed - Clinical trials for Temporomandibular Joint Disorders

Hyaluronic Acid Evaluation as Adjuvant to Temporomandibular Joint Arthroscopy

Start date: December 10, 2013
Phase: Phase 4
Study type: Interventional

This study evaluates the addition of hyaluronic acid to temporomandibular joint arthroscopy in the treatment of internal derangements in adults. A participants group will receive temporomandibular joint arthroscopy plus hyaluronic acid, while the other group will receive temporomandibular joint arthroscopy. Hypothesis: hyaluronic acid as an adjunct in temporomandibular joint arthroscopic surgery provides additional benefits in clinical and radiological outcomes in temporomandibular joint internal derangements.

NCT ID: NCT04109781 Completed - Clinical trials for To Evaluate the Effectiveness if Microscope in Discectomy

Short Clinical Outcome of Microscope Assisted Discectomy: Results of 90 Cases in Iraq

Start date: June 1, 2016
Phase: N/A
Study type: Interventional

A total of (90) patients involved in this study a randomized sampling use. The adult patient between (17) and (50) years of age complaining of lower back pain; and or radiculopathy and neurological symptoms, whom failed to respond to a (6-8) weeks period of conservative therapy (life style modification, NSAIDs, and physiotherapy). They are operated by Microscopic assisted discectomy and were followed by ODI and VAS for back pain and leg pain for 4 months after surgery

NCT ID: NCT04109560 Completed - COPD Exacerbation Clinical Trials

HFNC and Acute Hypercapnic Respiratory Failure

Start date: August 1, 2018
Phase:
Study type: Observational

High-flow nasal cannula (HFNC) enables delivering humidified gas at high-flow rates controlling the oxygen inspired fraction (FiO2). Its efficacy has been demonstrated in hypoxemic acute respiratory failure. However, little is known about its use in hypercapnic acute respiratory failure (ARF). Therefore, we aimed to evaluate the effect of using HFNC through "Precision Flow" equipment as first line of ventilatory support for COPD patients with hypercapnic acute respiratory failure.

NCT ID: NCT04108273 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Brain Plasticity Underlying Acquisition of New Organizational Skills in Children

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Organizational, time management and planning (OTMP) skills deficits are impairing features of developmental disorders, such as Attention Deficit Hyperactive Disorder (ADHD), which compromise school performance and family relations. The manualized Organizational Skills Training program (OST) was designed to target children's specific OTMP deficits. However, the brain mechanisms of treatment-induced changes remain unknown. The current study combines a training intervention (OST) with non-invasive MRI imaging in a pre-/post-design in a randomized two-arm (treatment vs. waitlist) trial to address this question.

NCT ID: NCT04108052 Completed - Clinical trials for Telangiectasia, Hereditary Hemorrhagic

Diagnostic Value of Ultra-low Dose Thoracic Scanner for the Pulmonary Arteriovenous Malformation Detection in HHT Patient

ULD OSLER
Start date: November 28, 2019
Phase: N/A
Study type: Interventional

Hereditary hemorrhagic telangiectasia (HHT) is linked to a dysregulation of angiogenesis leading to the formation of arteriovenous malformations (AVM): cutaneo-mucous telangiectasia and visceral shunts. The diagnosis is clinical and based on Curaçao criteria: recurrent epistaxis, cutaneo-mucous telangiectasia, hereditary signs and presence of visceral AVM. Pulmonary AVMs (PAVM) expose patients to many potentially life-threatening complications, such as strokes or brain abscesses due to the right-left shunt created and the lack of filtration barrier of the pulmonary capillary within the AVM. These patients should therefore have regular monitoring throughout their life by a chest CT scanner every 5 to 10 years in the absence of PAVM at the initial scan or more often if PAVMs are present. The management of PAVMs is based on their early detection and embolization in interventional radiology during which is set up within the afferent artery of the PAVM an embolizing agent, the coil. However, the risk of cumulative irradiation exposure from thoracic scanners and repeated thoracic embolizations over time could be reduces by a decrease of X-rays dose. A new thoracic CT imaging protocol validated in the United States in the primary screening of lung cancer, the ultra-low dose protocol, is a CT scanner acquired at an irradiation dose equivalent to that of a frontal chest x-ray and in profile. The dose reduction is of 40 times the usual dose of a chest CT scanner. The lung parenchyma has a high natural contrast on thoracic CT images and there are few adjacent attenuating structures allowing a drastic reduction of dose. However, from this dose, the image quality is degraded with an increase of the image noise. The diagnostic performances have to be confirmed with qualitative and quantitative measurements. Thus, the objective of this study is to compare the sensitivity and the specificity of the current scanner and the ultra-low dose scanner to reduce the exposure to X-rays.

NCT ID: NCT04107363 Completed - Clinical trials for Ventilator-associated Bacterial Pneumonia

Oropharyngeal Aspiration to Reduce Ventilator-Related Pneumonia

Start date: July 1, 2015
Phase: N/A
Study type: Interventional

Ventilator-associated pneumonia (VAP) is one of the healthcare-related infections that is common in critically ill patients, prolongs hospital stay, significantly increases mortality and additional health care costs. Microaspiration of oropharyngeal secretions the primary pathway in the formation of VAP has led researchers to focus on the detection of applications to prevent microbial colonization. Continuous or intermittent oropharyngeal aspiration, open system aspiration versus closed system aspiration, extensive oral care, oropharyngeal aspiration prior to patient positioning are some of these applications. When the patient is turned to position, the outbreak accumulated in the oral cavity is more likely to move to the lower respiratory tract. In this study, it is assumed that aspiration of oropharyngeal secretions prior to each position change will reduce the accumulation of oral secretion in the endotracheal tube cuff and reduce aspiration of contaminated secretion and reduce the risk of developing VIP. This randomized controlled experimental study was planned to confirm the validity of this assumption. This study was a randomized controlled experimental study designed to investigate the effect of oropharyngeal aspiration on decreasing the incidence of ventilator-associated pneumonia in patients receiving mechanical ventilation. The research was conducted between July 2015 and April 2019 in anesthesiology and reanimation intensive care unit. The study was carried out with 20 patients who underwent oropharyngeal aspiration as needed and 20 patients with oropharyngeal aspiration prior to each change of position.